Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia
Purpose: To determine the safety, efficacy, and tolerability of combinations of pilocarpine (Pilo) and oxymetazoline (Oxy) ocular drops dosed once daily and identify the optimal concentration of each for the pharmacologic treatment of presbyopia. Design: Two concurrent Phase 2, multicenter, double-m...
Guardado en:
Autores principales: | Francis W. Price, Jr., MD, Milton Hom, OD, Majid Moshirfar, MD, David Evans, OD, Haixia Liu, MD, PhD, Jeff Penzner, PharmD, Michael R. Robinson, MD, Sungwook Lee, PhD, David L. Wirta, MD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f3ff05453a3a427e87ac7613d6ea841d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Presbyopia Treatments by Mechanism of Action: A New Classification System Based on a Review of the Literature
por: Chang DH, et al.
Publicado: (2021) -
FEATURES OF VISUAL PERCEPTION IN PATIENTS WITH PRESBYOPIA, DEPENDING ON THE TYPE OF INTRAOCULAR CORRECTION
por: A. G. Shchuko, et al.
Publicado: (2016) -
Maximum human objectively measured pharmacologically stimulated accommodative amplitude
por: Grzybowski A, et al.
Publicado: (2018) -
Characterization of mouse salivary polypeptide secretion after oral administration of pilocarpine
por: LÓPEZ-SOLÍS,REMIGIO, et al.
Publicado: (2001) -
Substantial outcome improvement using a refined pilocarpine mouse model of temporal lobe epilepsy
por: Alexandre Vigier, et al.
Publicado: (2021)